Evidence map›Paper›PMID 32347512›Full record

ArticlePharmacoEconomics - open2020

Group Testing for SARS-CoV-2: Forward to the Past?

Koen B Pouwels, Laurence S J Roope, Adrian Barnett, David J Hunter, Terry M Nolan, Philip M Clarke

Abstract readLetter
In one paragraph

Article in PharmacoEconomics - open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Application of pooled testing in estimating the prevalence of COVID-19.Health services & outcomes research methodology · 2022
    Article
  2. Article
  3. Sample pooling strategies for SARS-CoV-2 detection.Journal of virological methods · 2021
    Review
  4. Article
  5. Considerations for Pooled Testing of Employees for SARS-CoV-2.Journal of occupational and environmental medicine · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Koen B PouwelsHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Laurence S J RoopeHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Adrian BarnettInstitute of Health Biomedical Innovation (IHBI), Queensland University of Technology, Brisbane, QLD, Australia.
David J HunterTranslational Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Terry M NolanThe Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
Philip M ClarkeHealth Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Philip.Clarke@ndph.ox.ac.uk.ORCID http://orcid.org/0000-0002-7555-5348

Funding

Cancer Research UK 29186National Institute for Health Research University of Oxford (NIHR-BRC-1215-20008)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32347512
PMCPMC7187661

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.